Problems of persistance of Plectridium tetani in the portal of entry in patients with tetanus.
D000293:Adolescent; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003017:Clostridium tetani / Q000302:isolation & purification*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010402:Penicillin G Procaine / Q000627:therapeutic use; D010403:Penicillin Resistance; D013307:Streptomycin / Q000627:therapeutic use; D013742:Tetanus / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D013743:Tetanus Antitoxin / Q000627:therapeutic use; D013745:Tetanus Toxoid / Q000627:therapeutic use; D014945:Wound Healing
D000900:Anti-Bacterial Agents; D013743:Tetanus Antitoxin; D013745:Tetanus Toxoid; D010402:Penicillin G Procaine; D013307:Streptomycin